Investor Overview

Investor Presentation
Financial News
May 29, 2020

-MDNA11, a long acting IL-2 super-agonist shows potent and durable tumor control with strong memory response in tumor models- -Up to 10-fold expansion of cancer-killing immune cells in non-human...

May 29, 2020

-Tumor control achieved in 76% of evaluable subjects irrespective of IL4R expression resulting in mOS, mPFS and PFS-12 of 15.0 months, 4.6 months and 33%, respectively- -In the Proposed Population...

Stock Quote
TSXMDNA
Stock Chart
TSXMDNA
Upcoming Events
Investor Contact
For more investor information, Please contact:
 
Elizabeth Williams, Chief Financial Officer
 
 
Email Alerts
* Required Fields